FIT BIOTECH OY |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.01 EUR | -.--% |
|
-28.57% | -.--% |
More press releases
FIT Biotech Oy is a Finland-based biotechnology company that develops and licenses its patented Gene Transport Unit (GTU) vector technology for new-generation medical treatments. The Company's GTU is a gene transport technology that solves challenge in the usability of gene therapy and deoxyribonucleic acid (DNA) vaccines. The Company primarily focuses on verifying the preclinical efficacy of its developed drug candidates (proof-of-concept). FIT Biotech Oy applies its GTU technology in seven drug development projects, including cancer (gene therapy), infectious diseases, such as human immunodeficiency virus (HIV) and tuberculosis, as well as animal vaccines.
| 1st Jan change | Capi. | |
|---|---|---|
| -3.30% | 102B | |
| +1.79% | 96.07B | |
| -1.57% | 21.66B | |
| -18.35% | 20.77B | |
| -8.79% | 18.53B | |
| -40.31% | 16.91B | |
| -26.84% | 13.79B | |
| +0.59% | 13.33B | |
| +20.86% | 10.94B |
- Stock Market
- Equities
- FITBIO Stock
